Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angong Niuhuang Pills in Acute Ischemic Stroke
NCT06883110Recruiting
- Sponsor
- Tongji Hospital
- Start
- Sep 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Angong Niuhuang Pill in ischemic stroke (3 arms), sponsored by Tongji Hospital. Primary endpoints: modified Rankin Score at Day 84, National Institutes of Health Stroke Scale at Day 84 and 1 more. Started Sep 2025; status: recruiting.
02
Drugs
Angong Niuhuang Pill
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06883110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06883110.